VIMAB Group AB (publ)
STO:VIMAB

Watchlist Manager

VIMAB Group AB (publ)

STO:VIMAB

Watchlist

Dividends

Discount Rate

Price: 7.4 SEK -0.67% Market Closed

Market Cap: 174.6m SEK

Have any thoughts about
VIMAB Group AB (publ)?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 7.4 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

VIMAB Alert

VIMAB Group AB (publ)

7.4

-0.05 (-0.67%)

52 Week Range	7.15 11.44
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

VIMAB Group AB (publ)

What unique competitive advantages
does VIMAB Group AB (publ) hold over its rivals?

What risks and challenges
does VIMAB Group AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of VIMAB Group AB (publ).

What unique competitive advantages
does VIMAB Group AB (publ) hold over its rivals?

What risks and challenges
does VIMAB Group AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for VIMAB Group AB (publ).

Provide P/S
for VIMAB Group AB (publ).

Provide P/E
for VIMAB Group AB (publ).

Provide P/OCF
for VIMAB Group AB (publ).

Provide P/FCFE
for VIMAB Group AB (publ).

Provide P/B
for VIMAB Group AB (publ).

Provide EV/S
for VIMAB Group AB (publ).

Provide EV/GP
for VIMAB Group AB (publ).

Provide EV/EBITDA
for VIMAB Group AB (publ).

Provide EV/EBIT
for VIMAB Group AB (publ).

Provide EV/OCF
for VIMAB Group AB (publ).

Provide EV/FCFF
for VIMAB Group AB (publ).

Provide EV/IC
for VIMAB Group AB (publ).

What are the Revenue projections
for VIMAB Group AB (publ)?

How accurate were the past Revenue estimates
for VIMAB Group AB (publ)?

What are the Net Income projections
for VIMAB Group AB (publ)?

How accurate were the past Net Income estimates
for VIMAB Group AB (publ)?

What are the EPS projections
for VIMAB Group AB (publ)?

How accurate were the past EPS estimates
for VIMAB Group AB (publ)?

What are the EBIT projections
for VIMAB Group AB (publ)?

How accurate were the past EBIT estimates
for VIMAB Group AB (publ)?

Compare the revenue forecasts
for VIMAB Group AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of VIMAB Group AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of VIMAB Group AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of VIMAB Group AB (publ) compared to its peers.

Compare the P/E ratios
of VIMAB Group AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing VIMAB Group AB (publ) with its peers.

Analyze the financial leverage
of VIMAB Group AB (publ) compared to its main competitors.

Show all profitability ratios
for VIMAB Group AB (publ).

Provide ROE
for VIMAB Group AB (publ).

Provide ROA
for VIMAB Group AB (publ).

Provide ROIC
for VIMAB Group AB (publ).

Provide ROCE
for VIMAB Group AB (publ).

Provide Gross Margin
for VIMAB Group AB (publ).

Provide Operating Margin
for VIMAB Group AB (publ).

Provide Net Margin
for VIMAB Group AB (publ).

Provide FCF Margin
for VIMAB Group AB (publ).

Show all solvency ratios
for VIMAB Group AB (publ).

Provide D/E Ratio
for VIMAB Group AB (publ).

Provide D/A Ratio
for VIMAB Group AB (publ).

Provide Interest Coverage Ratio
for VIMAB Group AB (publ).

Provide Altman Z-Score Ratio
for VIMAB Group AB (publ).

Provide Quick Ratio
for VIMAB Group AB (publ).

Provide Current Ratio
for VIMAB Group AB (publ).

Provide Cash Ratio
for VIMAB Group AB (publ).

What is the historical Revenue growth
over the last 5 years for VIMAB Group AB (publ)?

What is the historical Net Income growth
over the last 5 years for VIMAB Group AB (publ)?

What is the current Free Cash Flow
of VIMAB Group AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for VIMAB Group AB (publ).

P/E
Price to Earnings

-7.7

Current

-7.8

Median

19.9

Industry

Higher than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

-7.7

Market Cap

174.6m SEK

Net Income

-22.7m SEK

All Countries

Forward Multiples

			Market Cap	P/E
SE	V	VIMAB Group AB (publ) STO:VIMAB	174.6m SEK	-7.7
UK		Relx PLC LSE:REL	66.5B GBP	35.1
CA	T	Thomson Reuters Corp NYSE:TRI	76.3B USD	32.3
IE		Experian PLC LSE:EXPN	36.1B GBP	40.4
UK	I	IHS Markit Ltd F:0M3	37.9B EUR	35.1
NL	W	Wolters Kluwer NV VSE:WKL	36.7B EUR	35.4
US		Verisk Analytics Inc NASDAQ:VRSK	37.6B USD	42.3
US		Equifax Inc NYSE:EFX	35.9B USD	61.6
US		CoStar Group Inc NASDAQ:CSGP	30.7B USD	144.2
US		Leidos Holdings Inc NYSE:LDOS	21.5B USD	49.3
CH		SGS SA SIX:SGSN	18B CHF	32.9

				Earnings Growth
SE	V	VIMAB Group AB (publ) STO:VIMAB	Average P/E: 50.9 Negative Multiple: -7.7	N/A
UK		Relx PLC LSE:REL	35.1	57%
CA	T	Thomson Reuters Corp NYSE:TRI	32.3	-20%
IE		Experian PLC LSE:EXPN	40.4	52%
UK	I	IHS Markit Ltd F:0M3	35.1	N/A
NL	W	Wolters Kluwer NV VSE:WKL	35.4	36%
US		Verisk Analytics Inc NASDAQ:VRSK	42.3	91%
US		Equifax Inc NYSE:EFX	61.6	172%
US		CoStar Group Inc NASDAQ:CSGP	144.2	124%
US		Leidos Holdings Inc NYSE:LDOS	49.3	618%
CH		SGS SA SIX:SGSN	32.9	51%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

N/A

2-Years Forward

P/E

N/A

3-Years Forward

P/E

N/A

VIMAB Group AB (publ)
STO:VIMAB

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

VIMAB Group AB (publ) STO:VIMAB

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

VIMAB Group AB (publ)
STO:VIMAB

P/E
Price to Earnings